PHXM Annual SG&A
$12.88 M
-$3.65 M-22.09%
31 December 2022
Summary:
As of February 5, 2025, PHXM annual selling, general & administrative expenses is $12.88 million, with the most recent change of -$3.65 million (-22.09%) on December 31, 2022. During the last 3 years, it has fallen by -$5.49 million (-29.90%).PHXM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Quarterly SG&A
$3.22 M
0.00%
30 September 2023
Summary:
As of February 5, 2025, PHXM quarterly selling, general & administrative expenses is $3.22 millionOver the past year, it has increased by +$1.85 million (+134.77%).PHXM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM TTM SG&A
N/A
30 September 2023
Summary:
PHXM TTM selling, general & administrative expenses is not available.PHXM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHXM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.1% | +134.8% | - |
| 3 y3 years | -29.9% | +134.8% | - |
| 5 y5 years | +33.4% | +134.8% | - |
PHXM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -29.9% | -41.8% |
PHAXIAM Therapeutics SA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $3.22 M(+134.8%) | $4.60 M(-64.7%) |
| Dec 2022 | $12.88 M(-22.1%) | $1.37 M(-64.1%) | $13.01 M(-4.4%) |
| Sept 2022 | - | $3.83 M(+68.8%) | $13.62 M(-10.1%) |
| June 2022 | - | $2.27 M(-59.1%) | $15.15 M(-11.5%) |
| Mar 2022 | - | $5.54 M(+180.0%) | $17.13 M(+3.1%) |
| Dec 2021 | $16.53 M(+9.5%) | $1.98 M(-63.1%) | $16.61 M(-0.8%) |
| Sept 2021 | - | $5.36 M(+26.4%) | $16.74 M(+8.9%) |
| June 2021 | - | $4.24 M(-15.6%) | $15.37 M(+2.3%) |
| Mar 2021 | - | $5.03 M(+138.8%) | $15.03 M(+0.5%) |
| Dec 2020 | $15.09 M | $2.11 M(-47.3%) | $14.96 M(-5.4%) |
| Sept 2020 | - | $4.00 M(+2.4%) | $15.81 M(+0.5%) |
| June 2020 | - | $3.90 M(-21.2%) | $15.72 M(-8.6%) |
| Mar 2020 | - | $4.95 M(+67.5%) | $17.20 M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $2.96 M(-24.4%) | $17.76 M(-8.0%) |
| Dec 2019 | $18.37 M(+10.6%) | - | - |
| Sept 2019 | - | $3.91 M(-27.3%) | $19.30 M(+1.8%) |
| June 2019 | - | $5.38 M(-2.2%) | $18.96 M(+39.6%) |
| Mar 2019 | - | $5.51 M(+22.4%) | $13.58 M(+68.2%) |
| Dec 2018 | - | $4.50 M(+25.7%) | $8.07 M(+125.7%) |
| Dec 2018 | $16.62 M(+72.1%) | - | - |
| Sept 2018 | - | $3.58 M | $3.58 M |
| Dec 2017 | $9.65 M(+28.1%) | - | - |
| Dec 2016 | $7.53 M(-10.8%) | - | - |
| Dec 2015 | $8.45 M(+46.7%) | - | - |
| Dec 2014 | $5.76 M(+21.0%) | - | - |
| Dec 2013 | $4.76 M(+12.4%) | - | - |
| Dec 2012 | $4.24 M | - | - |
FAQ
- What is PHAXIAM Therapeutics SA annual selling, general & administrative expenses?
- What is the all time high annual SG&A for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual SG&A year-on-year change?
- What is PHAXIAM Therapeutics SA quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA quarterly SG&A year-on-year change?
- What is the all time high TTM SG&A for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual selling, general & administrative expenses?
The current annual SG&A of PHXM is $12.88 M
What is the all time high annual SG&A for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual selling, general & administrative expenses is $18.37 M
What is PHAXIAM Therapeutics SA annual SG&A year-on-year change?
Over the past year, PHXM annual selling, general & administrative expenses has changed by -$3.65 M (-22.09%)
What is PHAXIAM Therapeutics SA quarterly selling, general & administrative expenses?
The current quarterly SG&A of PHXM is $3.22 M
What is the all time high quarterly SG&A for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly selling, general & administrative expenses is $5.54 M
What is PHAXIAM Therapeutics SA quarterly SG&A year-on-year change?
Over the past year, PHXM quarterly selling, general & administrative expenses has changed by +$1.85 M (+134.77%)
What is the all time high TTM SG&A for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high TTM selling, general & administrative expenses is $19.30 M